Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Andrew E SimorCanadian Nosocomial Infection Surveillance Program

Abstract

BACKGROUND Bloodstream infection (BSI) due to methicillin-resistant Staphylococcus aureus (MRSA) is associated with considerable morbidity and mortality. OBJECTIVE To determine the incidence of MRSA BSI in Canadian hospitals and to identify variables associated with increased mortality. METHODS Prospective surveillance for MRSA BSI conducted in 53 Canadian hospitals from January 1, 2008, through December 31, 2012. Thirty-day all-cause mortality was determined, and logistic regression analysis was used to identify variables associated with mortality. RESULTS A total of 1,753 patients with MRSA BSI were identified (incidence, 0.45 per 1,000 admissions). The most common sites presumed to be the source of infection were skin/soft tissue (26.6%) and an intravascular catheter (22.0%). The most common spa types causing MRSA BSI were t002 (USA100/800; 55%) and t008 (USA300; 29%). Thirty-day all-cause mortality was 23.8%. Mortality was associated with increasing age (odds ratio, 1.03 per year [95% CI, 1.02-1.04]), the presence of pleuropulmonary infection (2.3 [1.4-3.7]), transfer to an intensive care unit (3.2 [2.1-5.0]), and failure to receive appropriate antimicrobial therapy within 24 hours of MRSA identification (3.2 [2.1-5.0]); a ...Continue Reading

References

Mar 11, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Sara E CosgroveYehuda Carmeli
Feb 8, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S-H KimK-W Choe
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alex SorianoJosep Mensa
May 14, 2009·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·George R GoldingUNKNOWN Canadian Nosocomial Infection Surveillance Program
Feb 13, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Andrew E SimorUNKNOWN Canadian Nosocomial Infection Surveillance Program
Oct 16, 2010·The Journal of Antimicrobial Chemotherapy·Mical PaulLeonard Leibovici
Oct 22, 2010·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·R KöckA W Friedrich
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Sebastiaan J van Hal, David L Paterson
Jan 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuUNKNOWN Infectious Diseases Society of America
Jun 28, 2011·American Journal of Infection Control·Leslie ForresterUNKNOWN CNISP Data Quality Working Group, and CNISP participating sites
Jul 22, 2011·The Journal of Antimicrobial Chemotherapy·Carla J WalravenRenée-Claude Mercier
Jan 10, 2012·The Journal of Antimicrobial Chemotherapy·Alan P JohnsonGeorgia Duckworth
Feb 4, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S J van HalD L Paterson
Mar 24, 2012·American Journal of Infection Control·William R JarvisRaymond Y Chinn
Jun 7, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pierre TattevinBinh An Diep
Jun 20, 2012·Emerging Infectious Diseases·Mina PastagiaStephen G Jenkins
Jan 22, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·O GaschUNKNOWN REIPI/GEIH Study Groups
Feb 14, 2013·The Journal of Antimicrobial Chemotherapy·O GaschUNKNOWN REIPI/GEIH Study Groups
Nov 15, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J O RobinsonR J Murray
Dec 18, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Rajeshwari NairMarin L Schweizer
Jun 1, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael Z DavidBrad Spellberg
Feb 14, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·V WilliamsUNKNOWN Infection Prevention and Control—Canada
Feb 28, 2015·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Andreas F WidmerReno Frei

❮ Previous
Next ❯

Citations

Oct 1, 2019·Annals of Internal Medicine·Kyle J PopovichDavid P Calfee
Nov 30, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D KnaflF Thalhammer
May 11, 2018·Journal of General and Family Medicine·Fumi YamasakiHiromi Seo
Jan 12, 2019·Journal of General and Family Medicine·Kaori MatsumotoHiromi Seo
Jun 14, 2020·Pharmacotherapy·Pramodini B Kale-PradhanMichael J Rybak
Apr 20, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael Z David
Jan 9, 2021·European Journal of Internal Medicine·Francesca GiovannenzeMassimo Fantoni
Nov 17, 2020·The Pediatric Infectious Disease Journal·Ethan CantyJessica E Ericson
May 22, 2021·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Masahiro ShirataToyohiro Hirai
Jul 9, 2021·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Xuehan LiYirong Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Jessica RenoJesse T Jacob
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Yoona RheeKyle J Popovich
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Andrew E SimorCanadian Nosocomial Infection Surveillance Program
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Valerie C CluzetEbbing Lautenbach
© 2022 Meta ULC. All rights reserved